Status:
COMPLETED
Automated Device for Asthma Monitoring and Management in Monitoring Adults With Lung Cancer Undergoing Radiation Therapy
Lead Sponsor:
Sidney Kimmel Cancer Center at Thomas Jefferson University
Collaborating Sponsors:
Health Care Originals, Inc.
Conditions:
Lung Carcinoma
Eligibility:
All Genders
18+ years
Brief Summary
This pilot early phase I trial studies the Automated Device for Asthma Monitoring and Management in monitoring adult patients with lung cancer who are undergoing radiation therapy. The Automated Devic...
Detailed Description
PRIMARY OBJECTIVES: I. Determine compliance with the Automated Device for Asthma Monitoring and Management (ADAMM) device in patients receiving radiation therapy (RT) for lung cancer. SECONDARY OBJE...
Eligibility Criteria
Inclusion
- Patients are capable of giving informed consent
- Patients are eligible to be treated with RT and plan to start treatment
- Patients have either metastatic or non-metastatic lung cancer as defined in history and physical
- Patients must be able to read or speak English
- Women of reproductive potential should have a negative serum or urine pregnancy test within one week prior to radiation planning CT scan
Exclusion
- Patients who cannot read or speak English
- Patients who are not candidates for RT treatment
- Women of childbearing potential who are pregnant or breastfeeding
Key Trial Info
Start Date :
March 20 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 25 2023
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT03340714
Start Date
March 20 2018
End Date
September 25 2023
Last Update
May 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sidney Kimmel Cancer Center at Thomas Jefferson University
Philadelphia, Pennsylvania, United States, 19107